share_log

SAB BIOTHERAPEUTICS INC C/WTS 22/10/2026 (TO PUR COM) | SC 13G: Statement of acquisition of beneficial ownership by individuals-BVF Partners L.P.(9.99%),BVF Inc.(9.99%), etc.

SAB BIOTHERAPEUTICS INC C/WTS 22/10/2026 (TO PUR COM) | SC 13G:超过5%持股股东披露文件-BVF Partners L.P.(9.99%),BVF Inc.(9.99%)等

SEC announcement ·  2023/12/04 16:33
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息